Syndax Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Jun 23 | SellUS$12,873 | Keith Goldan | Individual | 577 | US$22.31 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,299 | 0.0037% |
Individual Insiders | 336,729 | 0.377% |
Institutions | 88,940,340 | 99.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,585,221 | US$167.3m | -0.75% | 0.03% | |||
7,015,548 | US$154.7m | 19.3% | no data | |||
5,660,000 | US$124.8m | 57.2% | 9.32% | |||
5,016,224 | US$110.6m | 39.3% | no data | |||
4,335,353 | US$95.6m | 19.9% | no data | |||
4,222,222 | US$93.1m | 65.2% | 1.32% | |||
3,950,000 | US$87.1m | 40% | 3.31% | |||
3,383,244 | US$74.6m | 30.3% | 6.12% | |||
2,834,499 | US$62.5m | 23.2% | 0.13% | |||
2,737,520 | US$60.4m | 151% | 0.01% | |||
2,101,911 | US$46.3m | 248% | 0.1% | |||
1,875,000 | US$41.3m | 0% | 0.97% | |||
1,749,000 | US$38.6m | 36.2% | 0.53% | |||
1,544,216 | US$34.0m | 4,430% | 0.37% | |||
1,535,055 | US$33.8m | 12.8% | no data | |||
1,434,058 | US$31.6m | 194% | no data | |||
1,334,531 | US$29.4m | 0% | 0.01% | |||
1,175,000 | US$25.9m | 0% | 1.39% | |||
1,121,358 | US$24.7m | -6.3% | 0.01% | |||
1,094,494 | US$24.1m | 0% | 6.66% | |||
1,075,786 | US$23.7m | 14.2% | 1.78% | |||
1,025,000 | US$22.6m | 0% | 8.63% | |||
1,021,032 | US$22.5m | 325% | 0.06% | |||
951,607 | US$21.0m | 394% | 0.01% | |||
942,642 | US$20.8m | 114% | 0.02% |